Anticorps Monoclonal anti-TDP-43 (human specific)
TDP-43 (human specific) Monoclonal Antibody for FC (Intra)
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
FC (Intra)
Conjugaison
CoraLite® Plus 647 Fluorescent Dye
CloneNo.
6H6E12
N° de cat : CL647-60019
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | cellules MCF-7 |
Dilution recommandée
Application | Dilution |
---|---|
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL647-60019 cible TDP-43 (human specific) dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | TDP-43 (human specific) Protéine recombinante Ag1231 |
Nom complet | TAR DNA binding protein |
Masse moléculaire calculée | 43 kDa |
Poids moléculaire observé | 43 kDa |
Numéro d’acquisition GenBank | BC001487 |
Symbole du gène | TARDBP |
Identification du gène (NCBI) | 23435 |
Conjugaison | CoraLite® Plus 647 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 654 nm / 674 nm |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS avec glycérol à 50 %, Proclin300 à 0,05 % et BSA à 0,5 %, pH 7,3. |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Transactivation response (TAR) DNA-binding protein of 43 kDa (also known as TARDBP or TDP-43) was first isolated as a transcriptional inactivator binding to the TAR DNA element of the HIV-1 virus. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP-43, is the major component of the tau-negative and ubiquitin-positive inclusions that characterize amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal lobar degeneration (FTLD-U). Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659,19823856, 21666678, 22193176). 60019-2-Ig is a mouse monoclonal antibody recognizing the cleavage product of 20-30 kDa in addition to the native and phosphorylated forms of TDP-43. Immunohistochemical analyses of TDP-43 using this antibody detect both normal diffuse nuclear staining and insoluble inclusions in pathologic tissues. Notably this antibody only recognizes human TDP-43 but not reacts with mouse or rat TDP-43.
Protocole
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 647 TDP-43 (human specific) antibody CL647-60019 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |